1. Introduction {#sec1}
===============

Agha RA, Fowler AJ, Saetta A, Barai I, Rajmohan S, Orgill DP, for the SCARE Group. The SCARE Statement: Consensus-based surgical case report guidelines. International Journal of Surgery 2016 2016;34:180--186.

Cholecystectomy has been widely accepted as an effective treatment for acute cholecystitis (AC). The Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) were published in 2007 as the world\'s first guidelines for acute cholangitis and cholecystitis \[[@bib1]\]. Updated Tokyo Guidelines (TG13) were published in 2013 \[[@bib2]\]. The TG13 recommend laparoscopic cystectomy (LC) for the treatment of mild or moderate AC, and randomized controlled studies have shown benefits of early intervention \[[@bib3],[@bib4]\].

LC for AC is more difficult to perform than LC for non-AC \[[@bib5]\]. Intraoperative cholangiography is necessary to avoid bile duct injury when the identification of a cystic duct and common bile duct is difficult \[[@bib6]\]. We reported on intraoperative indocyanine green (ICG) fluorescence cholangiography \[[@bib7]\]. In this report, ICG was administered before the LC, and by using PINPOINT^®^, a bright-field, full-color, near-infrared fluorescence laparoscope, we obtained visualization equal to intraoperative conventional cholangiography. We report on an LC for AC using the PINPOINT^®^ Endoscopic Fluorescence Imaging System, as we could not find previous reports on the technique in this setting.

1.1. Case presentation {#sec1.1}
----------------------

An 85-year-old man presented to our hospital with pain in the right hypochondrium that had been present for 2 days. A painful mass was palpated in the right hypochondrium. Blood work showed elevation of white blood cell count (WBC; 22,900/μl), C-reactive protein (CRP; 2.21 mg/dl), and total bilirubin (T-Bil; 1.6 mg/dl). Abdominal computed tomography (CT) showed thickening of the gallbladder wall and surrounding inflammation ([Fig. 1](#fig1){ref-type="fig"}). Because no organ failure was detected, we diagnosed moderate AC (Grade Ⅱ) and performed an emergency operation.Fig. 1Abdominal computed tomography showed thickening of the gallbladder wall (arrow) and surrounding inflammation.Fig. 1

This surgery was approved by the Research Ethics Committee of the International University of Health and Welfare (Approval number 13-B-60).

Just before surgery, 10 ml of ICG 2.5 mg/ml was injected intravenously. LC was performed via four ports. First, a minilaparotomy was performed in the lower abdomen, and a 12-mm trocar was inserted. After CO~2~ insufflation (intra-abdominal pressure of 10 mmHg), a 30° oblique-viewing endoscope was inserted. Next, under laparoscopic visualization, a 12-mm trocar was inserted approximately 5 cm caudal to the epigastric region, a 5-mm trocar was inserted along the midclavicular line under the right costal arch, and a 5-mm trocar was inserted along the anterior axillary line under the right costal arch. Using PINPOINT^®^, the gallbladder and cystic duct were imaged in green ([Fig. 2](#fig2){ref-type="fig"}). To approach the cystic duct, the peripheral tissue was detached, and the critical view of safety proposed by Strasberg \[[@bib8]\] was verified in order to seal the cystic duct using an endoscopic clip. Subsequently, the cystic artery was sealed using an endoscopic clip ([Fig. 3](#fig3){ref-type="fig"}). The operative time was 81 minutes, and blood loss was 5 ml. The postoperative course was good, and the patient was discharged on day six after the operation.Fig. 2The gallbladder (arrowhead) and cystic duct (arrow) were imaged in green. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2Fig. 3The cystic duct (arrow) was sealed using an endoscopic clip.Fig. 3

2. Discussion {#sec2}
=============

Cholecystectomy has been widely accepted as a treatment for AC. Based on the TG07 and TG13, early intervention is preferred in Japan.

However, the incidence of intraoperative bile duct injury in patients with AC is higher than in those with non-AC \[[@bib5]\]. Traditionally, intraoperative cholangiography has been used to prevent bile duct injury \[[@bib6]\]. Intraoperative cystography is complicated, and the physician bears the additional burden of having to wear a radiation hazmat suit.

We reported on LC using the PINPOINT^®^ Endoscopic Fluorescence Imaging System with intraoperative fluorescent imaging in a patient with non-AC \[[@bib7]\], and applied the technique to LC in a patient with AC in the current report. ICG was administered before surgery, and when we used PINPOINT^®^, the liver, gall bladder, cystic duct, common bile duct, and the entire operation field appeared green in PINPOINT^®^ mode, the overlay image of the ICG fluorescence and full-color image, making it difficult to perform the operation. We displayed a color image on the main screen, and compared it with a dark field/black and white image on the sub-screen. In this way, we were able to identify a cystic duct with a common bile duct, and we completed the surgery without perioperative complications. This was a characteristic use of PINPOINT^®^, which allows the perioperative cystography image to be watched simultaneously with a sub-screen.

Three cases were reported only in cholecystectomy using PINPOINT, including this case \[[@bib9],[@bib10]\]. Konno et al. were using PINPOINT, but the number of cases were not mentioned. In the report by Konno et al. There were 6 cases of acute cholecystitis, but the patient background of cases of acute cholecystitis was unknown.

Two studies were describing the effectiveness of Fluorescent Cholangiography during surgery.

3. Conclusion {#sec3}
=============

The TG13 recommend laparoscopic cystectomy (LC) for the treatment of mild or moderate AC. To avoid complications as much as possible during surgery, I thought that using PINPOINT would be advantageous.
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